CHAPTER 34-51

INVESTIGATIONAL TREATMENTS

34-51-1      Definitions.
34-51-2      Eligible patient defined.
34-51-3      Written, informed consent.
34-51-4      Treatment with investigational drug, biological product, or device.
34-51-5      Treatment without compensation permitted.
34-51-6      Reimbursement of manufacturer from decedent's estate prohibited.
34-51-7      Health care provider not liable for recommendation.
34-51-8      Treating physician immune.
34-51-9      State employees prohibited from blocking eligible patient's access to investigational drug, biological product, or device.
34-51-10      Private cause of action not authorized.